nodes	percent_of_prediction	percent_of_DWPC	metapath
Amisulpride—DRD2—obesity	0.322	0.564	CbGaD
Amisulpride—HTR2A—obesity	0.249	0.436	CbGaD
Amisulpride—HTR7—sympathetic nervous system—obesity	0.00816	0.137	CbGeAlD
Amisulpride—HTR7—vagus nerve—obesity	0.0079	0.133	CbGeAlD
Amisulpride—HTR7—autonomic nervous system—obesity	0.00549	0.0923	CbGeAlD
Amisulpride—HTR2A—sympathetic nervous system—obesity	0.00509	0.0856	CbGeAlD
Amisulpride—HTR2A—vagus nerve—obesity	0.00493	0.0829	CbGeAlD
Amisulpride—HTR2A—autonomic nervous system—obesity	0.00342	0.0575	CbGeAlD
Amisulpride—HTR7—hindbrain—obesity	0.00231	0.0389	CbGeAlD
Amisulpride—DRD2—hindbrain—obesity	0.00219	0.0368	CbGeAlD
Amisulpride—Alizapride—DRD2—obesity	0.00162	0.258	CrCbGaD
Amisulpride—HTR2A—hindbrain—obesity	0.00144	0.0242	CbGeAlD
Amisulpride—HTR7—respiratory system—obesity	0.00141	0.0237	CbGeAlD
Amisulpride—HTR2B—adrenal cortex—obesity	0.00138	0.0233	CbGeAlD
Amisulpride—DRD2—respiratory system—obesity	0.00133	0.0224	CbGeAlD
Amisulpride—Remoxipride—DRD4—obesity	0.00132	0.211	CrCbGaD
Amisulpride—HTR2B—cardiovascular system—obesity	0.00126	0.0212	CbGeAlD
Amisulpride—HTR2B—adipose tissue—obesity	0.00111	0.0187	CbGeAlD
Amisulpride—HTR7—cardiovascular system—obesity	0.00108	0.0182	CbGeAlD
Amisulpride—HTR2B—digestive system—obesity	0.00105	0.0176	CbGeAlD
Amisulpride—HTR2B—adrenal gland—obesity	0.000999	0.0168	CbGeAlD
Amisulpride—DRD2—pituitary gland—obesity	0.000905	0.0152	CbGeAlD
Amisulpride—HTR7—digestive system—obesity	0.000897	0.0151	CbGeAlD
Amisulpride—HTR2A—respiratory system—obesity	0.00088	0.0148	CbGeAlD
Amisulpride—HTR7—adrenal gland—obesity	0.000855	0.0144	CbGeAlD
Amisulpride—Sulpiride—BCHE—obesity	0.000852	0.136	CrCbGaD
Amisulpride—Hypertension—Phentermine—obesity	0.00085	0.0043	CcSEcCtD
Amisulpride—Salivary hypersecretion—Bupropion—obesity	0.000843	0.00427	CcSEcCtD
Amisulpride—Constipation—Phendimetrazine—obesity	0.00084	0.00425	CcSEcCtD
Amisulpride—Tension—Diethylpropion—obesity	0.00084	0.00425	CcSEcCtD
Amisulpride—Nervousness—Diethylpropion—obesity	0.000832	0.00421	CcSEcCtD
Amisulpride—Hypersensitivity—Methamphetamine—obesity	0.000824	0.00417	CcSEcCtD
Amisulpride—Vaginal infection—Bupropion—obesity	0.00082	0.00415	CcSEcCtD
Amisulpride—Dry mouth—Phentermine—obesity	0.00082	0.00415	CcSEcCtD
Amisulpride—Hypokinesia—Topiramate—obesity	0.000819	0.00415	CcSEcCtD
Amisulpride—Menstrual disorder—Topiramate—obesity	0.000811	0.00411	CcSEcCtD
Amisulpride—Tremor—Diethylpropion—obesity	0.000802	0.00406	CcSEcCtD
Amisulpride—Hypersensitivity—Benzphetamine—obesity	0.000794	0.00402	CcSEcCtD
Amisulpride—Remoxipride—DRD2—obesity	0.000789	0.126	CrCbGaD
Amisulpride—Agitation—Diethylpropion—obesity	0.000787	0.00398	CcSEcCtD
Amisulpride—Hypotension—Phenylpropanolamine—obesity	0.000784	0.00397	CcSEcCtD
Amisulpride—Abdominal pain—Phendimetrazine—obesity	0.000777	0.00393	CcSEcCtD
Amisulpride—Gynaecomastia—Bupropion—obesity	0.000777	0.00393	CcSEcCtD
Amisulpride—Leukopenia—Diethylpropion—obesity	0.000766	0.00388	CcSEcCtD
Amisulpride—Diarrhoea—Methamphetamine—obesity	0.000765	0.00387	CcSEcCtD
Amisulpride—Insomnia—Phenylpropanolamine—obesity	0.000759	0.00384	CcSEcCtD
Amisulpride—Agitation—Cimetidine—obesity	0.000749	0.00379	CcSEcCtD
Amisulpride—Somnolence—Phenylpropanolamine—obesity	0.000746	0.00378	CcSEcCtD
Amisulpride—Convulsion—Diethylpropion—obesity	0.000742	0.00375	CcSEcCtD
Amisulpride—HTR7—endocrine gland—obesity	0.000741	0.0125	CbGeAlD
Amisulpride—Dizziness—Methamphetamine—obesity	0.000739	0.00374	CcSEcCtD
Amisulpride—Diarrhoea—Benzphetamine—obesity	0.000738	0.00373	CcSEcCtD
Amisulpride—Leukopenia—Cimetidine—obesity	0.000729	0.00369	CcSEcCtD
Amisulpride—Insomnia—Phentermine—obesity	0.000727	0.00368	CcSEcCtD
Amisulpride—Anxiety—Diethylpropion—obesity	0.000726	0.00368	CcSEcCtD
Amisulpride—Constipation—Phenylpropanolamine—obesity	0.000718	0.00363	CcSEcCtD
Amisulpride—Dizziness—Benzphetamine—obesity	0.000713	0.00361	CcSEcCtD
Amisulpride—Dry mouth—Diethylpropion—obesity	0.000713	0.00361	CcSEcCtD
Amisulpride—Dyspepsia—Phentermine—obesity	0.000707	0.00358	CcSEcCtD
Amisulpride—DRD2—endocrine gland—obesity	0.000701	0.0118	CbGeAlD
Amisulpride—Headache—Methamphetamine—obesity	0.0007	0.00354	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Phentermine—obesity	0.000694	0.00351	CcSEcCtD
Amisulpride—Fatigue—Phentermine—obesity	0.000693	0.0035	CcSEcCtD
Amisulpride—Anxiety—Cimetidine—obesity	0.000691	0.0035	CcSEcCtD
Amisulpride—Cardiac arrest—Sibutramine—obesity	0.000687	0.00348	CcSEcCtD
Amisulpride—Constipation—Phentermine—obesity	0.000687	0.00348	CcSEcCtD
Amisulpride—Hyperhidrosis—Diethylpropion—obesity	0.000676	0.00342	CcSEcCtD
Amisulpride—Headache—Benzphetamine—obesity	0.000675	0.00342	CcSEcCtD
Amisulpride—HTR2A—cardiovascular system—obesity	0.000674	0.0113	CbGeAlD
Amisulpride—Diarrhoea—Phendimetrazine—obesity	0.000672	0.0034	CcSEcCtD
Amisulpride—HTR7—liver—obesity	0.000669	0.0112	CbGeAlD
Amisulpride—Endocrine disorder—Topiramate—obesity	0.000667	0.00338	CcSEcCtD
Amisulpride—Sulpiride—DRD2—obesity	0.000661	0.106	CrCbGaD
Amisulpride—Orthostatic hypotension—Sibutramine—obesity	0.00066	0.00334	CcSEcCtD
Amisulpride—Dizziness—Phendimetrazine—obesity	0.00065	0.00329	CcSEcCtD
Amisulpride—Nausea—Benzphetamine—obesity	0.00064	0.00324	CcSEcCtD
Amisulpride—Urticaria—Phentermine—obesity	0.000638	0.00323	CcSEcCtD
Amisulpride—Abdominal pain—Phentermine—obesity	0.000635	0.00321	CcSEcCtD
Amisulpride—Breast pain—Topiramate—obesity	0.000634	0.00321	CcSEcCtD
Amisulpride—Insomnia—Diethylpropion—obesity	0.000632	0.0032	CcSEcCtD
Amisulpride—Cardiovascular disorder—Topiramate—obesity	0.000629	0.00319	CcSEcCtD
Amisulpride—Aggression—Topiramate—obesity	0.000629	0.00319	CcSEcCtD
Amisulpride—Amenorrhoea—Topiramate—obesity	0.000629	0.00319	CcSEcCtD
Amisulpride—Sweating increased—Orlistat—obesity	0.000629	0.00318	CcSEcCtD
Amisulpride—Somnolence—Diethylpropion—obesity	0.000621	0.00314	CcSEcCtD
Amisulpride—Hypersensitivity—Phenylpropanolamine—obesity	0.000618	0.00313	CcSEcCtD
Amisulpride—Headache—Phendimetrazine—obesity	0.000616	0.00312	CcSEcCtD
Amisulpride—Dyspepsia—Diethylpropion—obesity	0.000615	0.00311	CcSEcCtD
Amisulpride—Remoxipride—HTR2A—obesity	0.00061	0.0973	CrCbGaD
Amisulpride—Gastrointestinal disorder—Diethylpropion—obesity	0.000603	0.00305	CcSEcCtD
Amisulpride—Constipation—Diethylpropion—obesity	0.000598	0.00302	CcSEcCtD
Amisulpride—HTR2A—pituitary gland—obesity	0.000597	0.01	CbGeAlD
Amisulpride—Somnolence—Cimetidine—obesity	0.000591	0.00299	CcSEcCtD
Amisulpride—Dyskinesia—Topiramate—obesity	0.000589	0.00298	CcSEcCtD
Amisulpride—Nausea—Phendimetrazine—obesity	0.000584	0.00295	CcSEcCtD
Amisulpride—Asthenia—Phentermine—obesity	0.000576	0.00292	CcSEcCtD
Amisulpride—Orthostatic hypotension—Bupropion—obesity	0.000576	0.00291	CcSEcCtD
Amisulpride—Erectile dysfunction—Sibutramine—obesity	0.000575	0.00291	CcSEcCtD
Amisulpride—Depression—Orlistat—obesity	0.000574	0.0029	CcSEcCtD
Amisulpride—Fatigue—Cimetidine—obesity	0.000573	0.0029	CcSEcCtD
Amisulpride—Constipation—Cimetidine—obesity	0.000569	0.00288	CcSEcCtD
Amisulpride—Weight increased—Sibutramine—obesity	0.000569	0.00288	CcSEcCtD
Amisulpride—Neuropathy peripheral—Orlistat—obesity	0.000564	0.00286	CcSEcCtD
Amisulpride—Hyperglycaemia—Sibutramine—obesity	0.000564	0.00285	CcSEcCtD
Amisulpride—HTR2A—digestive system—obesity	0.00056	0.00941	CbGeAlD
Amisulpride—Depression—Sibutramine—obesity	0.000555	0.00281	CcSEcCtD
Amisulpride—Urticaria—Diethylpropion—obesity	0.000555	0.00281	CcSEcCtD
Amisulpride—Dizziness—Phenylpropanolamine—obesity	0.000555	0.00281	CcSEcCtD
Amisulpride—Pulmonary embolism—Topiramate—obesity	0.000553	0.0028	CcSEcCtD
Amisulpride—Vaginal inflammation—Topiramate—obesity	0.000553	0.0028	CcSEcCtD
Amisulpride—Diarrhoea—Phentermine—obesity	0.00055	0.00278	CcSEcCtD
Amisulpride—Neuropathy peripheral—Sibutramine—obesity	0.000546	0.00276	CcSEcCtD
Amisulpride—Salivary hypersecretion—Topiramate—obesity	0.000537	0.00272	CcSEcCtD
Amisulpride—Vomiting—Phenylpropanolamine—obesity	0.000534	0.0027	CcSEcCtD
Amisulpride—HTR2A—adrenal gland—obesity	0.000533	0.00897	CbGeAlD
Amisulpride—Dizziness—Phentermine—obesity	0.000531	0.00269	CcSEcCtD
Amisulpride—Sweating increased—Bupropion—obesity	0.000531	0.00268	CcSEcCtD
Amisulpride—Vaginal infection—Topiramate—obesity	0.000522	0.00264	CcSEcCtD
Amisulpride—Vomiting—Phentermine—obesity	0.000511	0.00258	CcSEcCtD
Amisulpride—Bradycardia—Sibutramine—obesity	0.000509	0.00258	CcSEcCtD
Amisulpride—Headache—Phentermine—obesity	0.000503	0.00255	CcSEcCtD
Amisulpride—Erectile dysfunction—Bupropion—obesity	0.000502	0.00254	CcSEcCtD
Amisulpride—Nausea—Phenylpropanolamine—obesity	0.000499	0.00252	CcSEcCtD
Amisulpride—Weight increased—Bupropion—obesity	0.000496	0.00251	CcSEcCtD
Amisulpride—Weight decreased—Bupropion—obesity	0.000493	0.00249	CcSEcCtD
Amisulpride—Hyperglycaemia—Bupropion—obesity	0.000491	0.00249	CcSEcCtD
Amisulpride—Hypersensitivity—Cimetidine—obesity	0.00049	0.00248	CcSEcCtD
Amisulpride—Diarrhoea—Diethylpropion—obesity	0.000478	0.00242	CcSEcCtD
Amisulpride—Nausea—Phentermine—obesity	0.000477	0.00241	CcSEcCtD
Amisulpride—Asthenia—Cimetidine—obesity	0.000477	0.00241	CcSEcCtD
Amisulpride—Neuropathy peripheral—Bupropion—obesity	0.000476	0.00241	CcSEcCtD
Amisulpride—Immune system disorder—Orlistat—obesity	0.000467	0.00236	CcSEcCtD
Amisulpride—HTR2A—endocrine gland—obesity	0.000462	0.00778	CbGeAlD
Amisulpride—Dizziness—Diethylpropion—obesity	0.000462	0.00234	CcSEcCtD
Amisulpride—Diarrhoea—Cimetidine—obesity	0.000455	0.0023	CcSEcCtD
Amisulpride—Angiopathy—Sibutramine—obesity	0.000454	0.0023	CcSEcCtD
Amisulpride—Mental disorder—Orlistat—obesity	0.000453	0.00229	CcSEcCtD
Amisulpride—Immune system disorder—Sibutramine—obesity	0.000452	0.00229	CcSEcCtD
Amisulpride—Malnutrition—Orlistat—obesity	0.00045	0.00228	CcSEcCtD
Amisulpride—Vomiting—Diethylpropion—obesity	0.000444	0.00225	CcSEcCtD
Amisulpride—Dizziness—Cimetidine—obesity	0.00044	0.00223	CcSEcCtD
Amisulpride—Headache—Diethylpropion—obesity	0.000438	0.00222	CcSEcCtD
Amisulpride—Malnutrition—Sibutramine—obesity	0.000435	0.0022	CcSEcCtD
Amisulpride—Muscle spasms—Orlistat—obesity	0.000432	0.00219	CcSEcCtD
Amisulpride—Tension—Sibutramine—obesity	0.000427	0.00216	CcSEcCtD
Amisulpride—Nervousness—Sibutramine—obesity	0.000423	0.00214	CcSEcCtD
Amisulpride—Vomiting—Cimetidine—obesity	0.000423	0.00214	CcSEcCtD
Amisulpride—Muscle spasms—Sibutramine—obesity	0.000419	0.00212	CcSEcCtD
Amisulpride—HTR2A—liver—obesity	0.000417	0.00701	CbGeAlD
Amisulpride—Headache—Cimetidine—obesity	0.000417	0.00211	CcSEcCtD
Amisulpride—Nausea—Diethylpropion—obesity	0.000415	0.0021	CcSEcCtD
Amisulpride—Metoclopramide—DRD2—obesity	0.000415	0.0662	CrCbGaD
Amisulpride—Angioedema—Orlistat—obesity	0.000411	0.00208	CcSEcCtD
Amisulpride—Tremor—Sibutramine—obesity	0.000408	0.00206	CcSEcCtD
Amisulpride—Cardiac disorder—Bupropion—obesity	0.000405	0.00205	CcSEcCtD
Amisulpride—Agitation—Sibutramine—obesity	0.0004	0.00202	CcSEcCtD
Amisulpride—Angioedema—Sibutramine—obesity	0.000398	0.00201	CcSEcCtD
Amisulpride—Angiopathy—Bupropion—obesity	0.000396	0.002	CcSEcCtD
Amisulpride—Nausea—Cimetidine—obesity	0.000395	0.002	CcSEcCtD
Amisulpride—Immune system disorder—Bupropion—obesity	0.000394	0.00199	CcSEcCtD
Amisulpride—Convulsion—Orlistat—obesity	0.00039	0.00197	CcSEcCtD
Amisulpride—Leukopenia—Sibutramine—obesity	0.00039	0.00197	CcSEcCtD
Amisulpride—Mental disorder—Bupropion—obesity	0.000382	0.00193	CcSEcCtD
Amisulpride—Anxiety—Orlistat—obesity	0.000382	0.00193	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.00038	0.00192	CcSEcCtD
Amisulpride—Malnutrition—Bupropion—obesity	0.00038	0.00192	CcSEcCtD
Amisulpride—Convulsion—Sibutramine—obesity	0.000377	0.00191	CcSEcCtD
Amisulpride—Hypertension—Sibutramine—obesity	0.000376	0.0019	CcSEcCtD
Amisulpride—Dry mouth—Orlistat—obesity	0.000375	0.0019	CcSEcCtD
Amisulpride—Tension—Bupropion—obesity	0.000372	0.00188	CcSEcCtD
Amisulpride—Anxiety—Sibutramine—obesity	0.000369	0.00187	CcSEcCtD
Amisulpride—Nervousness—Bupropion—obesity	0.000369	0.00187	CcSEcCtD
Amisulpride—Orthostatic hypotension—Topiramate—obesity	0.000367	0.00186	CcSEcCtD
Amisulpride—Muscle spasms—Bupropion—obesity	0.000365	0.00185	CcSEcCtD
Amisulpride—Dry mouth—Sibutramine—obesity	0.000362	0.00183	CcSEcCtD
Amisulpride—Nervous system disorder—Orlistat—obesity	0.00036	0.00182	CcSEcCtD
Amisulpride—Skin disorder—Orlistat—obesity	0.000357	0.0018	CcSEcCtD
Amisulpride—Tremor—Bupropion—obesity	0.000356	0.0018	CcSEcCtD
Amisulpride—Hyperhidrosis—Orlistat—obesity	0.000355	0.0018	CcSEcCtD
Amisulpride—Agitation—Bupropion—obesity	0.000349	0.00176	CcSEcCtD
Amisulpride—Angioedema—Bupropion—obesity	0.000347	0.00175	CcSEcCtD
Amisulpride—Skin disorder—Sibutramine—obesity	0.000345	0.00175	CcSEcCtD
Amisulpride—Hyperhidrosis—Sibutramine—obesity	0.000343	0.00174	CcSEcCtD
Amisulpride—Leukopenia—Bupropion—obesity	0.00034	0.00172	CcSEcCtD
Amisulpride—Sweating increased—Topiramate—obesity	0.000338	0.00171	CcSEcCtD
Amisulpride—Insomnia—Orlistat—obesity	0.000332	0.00168	CcSEcCtD
Amisulpride—Hypotension—Sibutramine—obesity	0.000332	0.00168	CcSEcCtD
Amisulpride—Convulsion—Bupropion—obesity	0.000329	0.00166	CcSEcCtD
Amisulpride—Hypertension—Bupropion—obesity	0.000328	0.00166	CcSEcCtD
Amisulpride—Neutropenia—Topiramate—obesity	0.000324	0.00164	CcSEcCtD
Amisulpride—Dyspepsia—Orlistat—obesity	0.000323	0.00164	CcSEcCtD
Amisulpride—Anxiety—Bupropion—obesity	0.000322	0.00163	CcSEcCtD
Amisulpride—Insomnia—Sibutramine—obesity	0.000321	0.00163	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000321	0.00162	CcSEcCtD
Amisulpride—Erectile dysfunction—Topiramate—obesity	0.00032	0.00162	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Orlistat—obesity	0.000317	0.0016	CcSEcCtD
Amisulpride—Fatigue—Orlistat—obesity	0.000317	0.0016	CcSEcCtD
Amisulpride—Dry mouth—Bupropion—obesity	0.000316	0.0016	CcSEcCtD
Amisulpride—Somnolence—Sibutramine—obesity	0.000316	0.0016	CcSEcCtD
Amisulpride—Weight increased—Topiramate—obesity	0.000316	0.0016	CcSEcCtD
Amisulpride—Weight decreased—Topiramate—obesity	0.000314	0.00159	CcSEcCtD
Amisulpride—Hyperglycaemia—Topiramate—obesity	0.000313	0.00158	CcSEcCtD
Amisulpride—Dyspepsia—Sibutramine—obesity	0.000313	0.00158	CcSEcCtD
Amisulpride—Depression—Topiramate—obesity	0.000309	0.00156	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Sibutramine—obesity	0.000307	0.00155	CcSEcCtD
Amisulpride—Constipation—Sibutramine—obesity	0.000304	0.00154	CcSEcCtD
Amisulpride—Nervous system disorder—Bupropion—obesity	0.000304	0.00154	CcSEcCtD
Amisulpride—Neuropathy peripheral—Topiramate—obesity	0.000303	0.00153	CcSEcCtD
Amisulpride—Skin disorder—Bupropion—obesity	0.000301	0.00152	CcSEcCtD
Amisulpride—Gastrointestinal pain—Orlistat—obesity	0.0003	0.00152	CcSEcCtD
Amisulpride—Hyperhidrosis—Bupropion—obesity	0.000299	0.00152	CcSEcCtD
Amisulpride—Urticaria—Orlistat—obesity	0.000292	0.00148	CcSEcCtD
Amisulpride—Gastrointestinal pain—Sibutramine—obesity	0.000291	0.00147	CcSEcCtD
Amisulpride—Abdominal pain—Orlistat—obesity	0.00029	0.00147	CcSEcCtD
Amisulpride—Hypotension—Bupropion—obesity	0.000289	0.00146	CcSEcCtD
Amisulpride—Agranulocytosis—Topiramate—obesity	0.000289	0.00146	CcSEcCtD
Amisulpride—Bradycardia—Topiramate—obesity	0.000283	0.00143	CcSEcCtD
Amisulpride—Urticaria—Sibutramine—obesity	0.000282	0.00143	CcSEcCtD
Amisulpride—Abdominal pain—Sibutramine—obesity	0.000281	0.00142	CcSEcCtD
Amisulpride—Insomnia—Bupropion—obesity	0.00028	0.00142	CcSEcCtD
Amisulpride—Somnolence—Bupropion—obesity	0.000275	0.00139	CcSEcCtD
Amisulpride—Dyspepsia—Bupropion—obesity	0.000273	0.00138	CcSEcCtD
Amisulpride—Hypersensitivity—Orlistat—obesity	0.00027	0.00137	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Bupropion—obesity	0.000267	0.00135	CcSEcCtD
Amisulpride—Fatigue—Bupropion—obesity	0.000267	0.00135	CcSEcCtD
Amisulpride—Constipation—Bupropion—obesity	0.000265	0.00134	CcSEcCtD
Amisulpride—Asthenia—Orlistat—obesity	0.000263	0.00133	CcSEcCtD
Amisulpride—Hypersensitivity—Sibutramine—obesity	0.000262	0.00132	CcSEcCtD
Amisulpride—Pruritus—Orlistat—obesity	0.00026	0.00131	CcSEcCtD
Amisulpride—Cardiac disorder—Topiramate—obesity	0.000258	0.0013	CcSEcCtD
Amisulpride—Asthenia—Sibutramine—obesity	0.000255	0.00129	CcSEcCtD
Amisulpride—Gastrointestinal pain—Bupropion—obesity	0.000253	0.00128	CcSEcCtD
Amisulpride—Angiopathy—Topiramate—obesity	0.000252	0.00128	CcSEcCtD
Amisulpride—Pruritus—Sibutramine—obesity	0.000251	0.00127	CcSEcCtD
Amisulpride—Diarrhoea—Orlistat—obesity	0.000251	0.00127	CcSEcCtD
Amisulpride—Immune system disorder—Topiramate—obesity	0.000251	0.00127	CcSEcCtD
Amisulpride—Urticaria—Bupropion—obesity	0.000246	0.00125	CcSEcCtD
Amisulpride—Abdominal pain—Bupropion—obesity	0.000245	0.00124	CcSEcCtD
Amisulpride—Mental disorder—Topiramate—obesity	0.000243	0.00123	CcSEcCtD
Amisulpride—Diarrhoea—Sibutramine—obesity	0.000243	0.00123	CcSEcCtD
Amisulpride—Dizziness—Orlistat—obesity	0.000243	0.00123	CcSEcCtD
Amisulpride—Malnutrition—Topiramate—obesity	0.000242	0.00122	CcSEcCtD
Amisulpride—Tension—Topiramate—obesity	0.000237	0.0012	CcSEcCtD
Amisulpride—Dizziness—Sibutramine—obesity	0.000235	0.00119	CcSEcCtD
Amisulpride—Nervousness—Topiramate—obesity	0.000235	0.00119	CcSEcCtD
Amisulpride—Vomiting—Orlistat—obesity	0.000233	0.00118	CcSEcCtD
Amisulpride—Muscle spasms—Topiramate—obesity	0.000232	0.00118	CcSEcCtD
Amisulpride—Headache—Orlistat—obesity	0.00023	0.00116	CcSEcCtD
Amisulpride—Hypersensitivity—Bupropion—obesity	0.000228	0.00115	CcSEcCtD
Amisulpride—Tremor—Topiramate—obesity	0.000227	0.00115	CcSEcCtD
Amisulpride—Vomiting—Sibutramine—obesity	0.000226	0.00114	CcSEcCtD
Amisulpride—Headache—Sibutramine—obesity	0.000223	0.00113	CcSEcCtD
Amisulpride—Asthenia—Bupropion—obesity	0.000222	0.00112	CcSEcCtD
Amisulpride—Agitation—Topiramate—obesity	0.000222	0.00112	CcSEcCtD
Amisulpride—Pruritus—Bupropion—obesity	0.000219	0.00111	CcSEcCtD
Amisulpride—Nausea—Orlistat—obesity	0.000218	0.0011	CcSEcCtD
Amisulpride—Leukopenia—Topiramate—obesity	0.000216	0.0011	CcSEcCtD
Amisulpride—Diarrhoea—Bupropion—obesity	0.000212	0.00107	CcSEcCtD
Amisulpride—Nausea—Sibutramine—obesity	0.000211	0.00107	CcSEcCtD
Amisulpride—Convulsion—Topiramate—obesity	0.000209	0.00106	CcSEcCtD
Amisulpride—Hypertension—Topiramate—obesity	0.000209	0.00106	CcSEcCtD
Amisulpride—Anxiety—Topiramate—obesity	0.000205	0.00104	CcSEcCtD
Amisulpride—Dizziness—Bupropion—obesity	0.000205	0.00104	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000204	0.00103	CcSEcCtD
Amisulpride—Dry mouth—Topiramate—obesity	0.000201	0.00102	CcSEcCtD
Amisulpride—Vomiting—Bupropion—obesity	0.000197	0.000997	CcSEcCtD
Amisulpride—Headache—Bupropion—obesity	0.000194	0.000982	CcSEcCtD
Amisulpride—Nervous system disorder—Topiramate—obesity	0.000194	0.000979	CcSEcCtD
Amisulpride—Skin disorder—Topiramate—obesity	0.000192	0.00097	CcSEcCtD
Amisulpride—Hyperhidrosis—Topiramate—obesity	0.000191	0.000965	CcSEcCtD
Amisulpride—Hypotension—Topiramate—obesity	0.000184	0.000933	CcSEcCtD
Amisulpride—Nausea—Bupropion—obesity	0.000184	0.000931	CcSEcCtD
Amisulpride—Insomnia—Topiramate—obesity	0.000178	0.000903	CcSEcCtD
Amisulpride—Somnolence—Topiramate—obesity	0.000175	0.000888	CcSEcCtD
Amisulpride—Dyspepsia—Topiramate—obesity	0.000174	0.000879	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Topiramate—obesity	0.00017	0.000862	CcSEcCtD
Amisulpride—Fatigue—Topiramate—obesity	0.00017	0.000861	CcSEcCtD
Amisulpride—Constipation—Topiramate—obesity	0.000169	0.000854	CcSEcCtD
Amisulpride—Gastrointestinal pain—Topiramate—obesity	0.000161	0.000817	CcSEcCtD
Amisulpride—Urticaria—Topiramate—obesity	0.000157	0.000793	CcSEcCtD
Amisulpride—Abdominal pain—Topiramate—obesity	0.000156	0.000789	CcSEcCtD
Amisulpride—Hypersensitivity—Topiramate—obesity	0.000145	0.000736	CcSEcCtD
Amisulpride—Asthenia—Topiramate—obesity	0.000142	0.000716	CcSEcCtD
Amisulpride—Pruritus—Topiramate—obesity	0.00014	0.000707	CcSEcCtD
Amisulpride—Diarrhoea—Topiramate—obesity	0.000135	0.000683	CcSEcCtD
Amisulpride—Dizziness—Topiramate—obesity	0.00013	0.00066	CcSEcCtD
Amisulpride—Vomiting—Topiramate—obesity	0.000125	0.000635	CcSEcCtD
Amisulpride—Headache—Topiramate—obesity	0.000124	0.000626	CcSEcCtD
Amisulpride—Nausea—Topiramate—obesity	0.000117	0.000593	CcSEcCtD
Amisulpride—HTR2B—Signaling Pathways—C3—obesity	1.02e-05	6.17e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—PIK3CG—obesity	1.02e-05	6.15e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—GCG—obesity	1.01e-05	6.12e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PTPN1—obesity	1.01e-05	6.12e-05	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—PIK3CD—obesity	1e-05	6.05e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—ESR1—obesity	9.94e-06	6.01e-05	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—PIK3CD—obesity	9.85e-06	5.96e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—POMC—obesity	9.85e-06	5.95e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PRL—obesity	9.82e-06	5.94e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PRKCB—obesity	9.82e-06	5.93e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—F2—obesity	9.82e-06	5.93e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PRKCD—obesity	9.73e-06	5.88e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IRS2—obesity	9.72e-06	5.87e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—AGT—obesity	9.71e-06	5.87e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—BAD—obesity	9.7e-06	5.86e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—POMC—obesity	9.69e-06	5.86e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—STK11—obesity	9.68e-06	5.85e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PRL—obesity	9.66e-06	5.84e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CCL2—obesity	9.64e-06	5.82e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PLG—obesity	9.57e-06	5.78e-05	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—RHOA—obesity	9.56e-06	5.77e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—STK11—obesity	9.52e-06	5.76e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—HTR2A—obesity	9.52e-06	5.75e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—APOE—obesity	9.51e-06	5.75e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—LEP—obesity	9.51e-06	5.75e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—C3—obesity	9.51e-06	5.74e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CCL2—obesity	9.48e-06	5.73e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—AKT2—obesity	9.47e-06	5.72e-05	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—PIK3R1—obesity	9.46e-06	5.72e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CAV1—obesity	9.42e-06	5.69e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PLG—obesity	9.42e-06	5.69e-05	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—RHOA—obesity	9.4e-06	5.68e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—APOA1—obesity	9.4e-06	5.68e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PIK3CG—obesity	9.39e-06	5.68e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—FOXO3—obesity	9.34e-06	5.65e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—ADRB2—obesity	9.32e-06	5.63e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—AKT2—obesity	9.31e-06	5.63e-05	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—PIK3R1—obesity	9.31e-06	5.62e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IRS1—obesity	9.29e-06	5.61e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—FOXO3—obesity	9.19e-06	5.56e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—SOCS1—obesity	9.18e-06	5.55e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—ADRB2—obesity	9.17e-06	5.54e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—PIK3CD—obesity	9.1e-06	5.5e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—ESR1—obesity	9.08e-06	5.49e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—SOCS3—obesity	9.06e-06	5.48e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IRS2—obesity	9.04e-06	5.47e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—AGT—obesity	9.03e-06	5.46e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—SOCS1—obesity	9.03e-06	5.46e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—F2—obesity	8.97e-06	5.42e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PRKCB—obesity	8.97e-06	5.42e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—PIK3CD—obesity	8.95e-06	5.41e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—POMC—obesity	8.94e-06	5.4e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—SOCS3—obesity	8.92e-06	5.39e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—INS—obesity	8.89e-06	5.37e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—GNB3—obesity	8.87e-06	5.36e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—BAD—obesity	8.86e-06	5.36e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—APOE—obesity	8.85e-06	5.35e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—LEP—obesity	8.85e-06	5.35e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CAV1—obesity	8.77e-06	5.3e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—TYK2—obesity	8.75e-06	5.29e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CCL2—obesity	8.75e-06	5.29e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—APOA1—obesity	8.75e-06	5.29e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—GNB3—obesity	8.73e-06	5.28e-05	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—PIK3CB—obesity	8.73e-06	5.28e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IGF2—obesity	8.72e-06	5.27e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—RHOA—obesity	8.68e-06	5.24e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—GNAS—obesity	8.64e-06	5.22e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—TYK2—obesity	8.61e-06	5.2e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IGF1—obesity	8.6e-06	5.2e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—AKT2—obesity	8.59e-06	5.19e-05	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—PIK3CB—obesity	8.59e-06	5.19e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—PIK3R1—obesity	8.59e-06	5.19e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PIK3CG—obesity	8.58e-06	5.19e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IGF2—obesity	8.58e-06	5.18e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—RHOA—obesity	8.54e-06	5.16e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—GNAS—obesity	8.5e-06	5.14e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IRS1—obesity	8.48e-06	5.13e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—APOB—obesity	8.46e-06	5.11e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—PIK3R1—obesity	8.45e-06	5.11e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—ESR1—obesity	8.45e-06	5.11e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—F2—obesity	8.35e-06	5.04e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PRKCB—obesity	8.35e-06	5.04e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—APOB—obesity	8.33e-06	5.03e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCL5—obesity	8.26e-06	4.99e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PIK3CD—obesity	8.26e-06	4.99e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—BAD—obesity	8.25e-06	4.98e-05	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—PIK3CA—obesity	8.18e-06	4.94e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—POMC—obesity	8.17e-06	4.94e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—SERPINE1—obesity	8.17e-06	4.94e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCL5—obesity	8.13e-06	4.91e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—INS—obesity	8.13e-06	4.91e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—LPL—obesity	8.08e-06	4.88e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—FOXO1—obesity	8.02e-06	4.85e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—RPS6KB1—obesity	8.01e-06	4.84e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CCL2—obesity	7.99e-06	4.83e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PIK3CG—obesity	7.99e-06	4.83e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—LPL—obesity	7.95e-06	4.8e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—TYK2—obesity	7.94e-06	4.8e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—PIK3CB—obesity	7.93e-06	4.79e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IRS1—obesity	7.89e-06	4.77e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—FOXO1—obesity	7.89e-06	4.77e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—RHOA—obesity	7.88e-06	4.76e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—RPS6KB1—obesity	7.88e-06	4.76e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IGF1—obesity	7.86e-06	4.75e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—AKT2—obesity	7.85e-06	4.75e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—PIK3CB—obesity	7.8e-06	4.71e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PIK3R1—obesity	7.8e-06	4.71e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—NOS3—obesity	7.8e-06	4.71e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—POMC—obesity	7.6e-06	4.59e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—INS—obesity	7.56e-06	4.57e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PIK3CD—obesity	7.55e-06	4.56e-05	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—PIK3CA—obesity	7.47e-06	4.52e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—SERPINE1—obesity	7.46e-06	4.51e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PRKCD—obesity	7.44e-06	4.5e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CCL2—obesity	7.44e-06	4.5e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—PIK3CA—obesity	7.43e-06	4.49e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PRKCD—obesity	7.32e-06	4.43e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IGF1—obesity	7.31e-06	4.42e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—AKT2—obesity	7.31e-06	4.42e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—HTR2A—obesity	7.28e-06	4.4e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—C3—obesity	7.27e-06	4.4e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—TYK2—obesity	7.26e-06	4.39e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—RHOA—obesity	7.2e-06	4.35e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PIK3CB—obesity	7.2e-06	4.35e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MTOR—obesity	7.2e-06	4.35e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—C3—obesity	7.16e-06	4.33e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—NOS3—obesity	7.13e-06	4.31e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PIK3R1—obesity	7.13e-06	4.31e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PIK3CD—obesity	7.02e-06	4.24e-05	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—PIK3CA—obesity	6.95e-06	4.2e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—SERPINE1—obesity	6.94e-06	4.2e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IRS2—obesity	6.92e-06	4.18e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—AGT—obesity	6.91e-06	4.18e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IRS2—obesity	6.81e-06	4.11e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—AGT—obesity	6.8e-06	4.11e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—PIK3CA—obesity	6.79e-06	4.1e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—APOE—obesity	6.77e-06	4.09e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—LEP—obesity	6.77e-06	4.09e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—TYK2—obesity	6.75e-06	4.08e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CAV1—obesity	6.71e-06	4.05e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—RHOA—obesity	6.7e-06	4.05e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—APOA1—obesity	6.69e-06	4.05e-05	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—AKT1—obesity	6.68e-06	4.04e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—LEP—obesity	6.66e-06	4.03e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—APOE—obesity	6.66e-06	4.03e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PIK3R1—obesity	6.63e-06	4.01e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—NOS3—obesity	6.63e-06	4.01e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CAV1—obesity	6.6e-06	3.99e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—APOA1—obesity	6.59e-06	3.98e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MTOR—obesity	6.58e-06	3.97e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PIK3CB—obesity	6.58e-06	3.97e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—IL6—obesity	6.58e-06	3.97e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—ESR1—obesity	6.47e-06	3.91e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PRKCB—obesity	6.39e-06	3.86e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—F2—obesity	6.39e-06	3.86e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—ESR1—obesity	6.36e-06	3.84e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—PIK3CA—obesity	6.32e-06	3.82e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—BAD—obesity	6.31e-06	3.81e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PRKCB—obesity	6.28e-06	3.8e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—F2—obesity	6.28e-06	3.8e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MMP9—obesity	6.26e-06	3.78e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—BAD—obesity	6.21e-06	3.75e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PIK3CB—obesity	6.12e-06	3.7e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MTOR—obesity	6.12e-06	3.7e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PIK3CG—obesity	6.11e-06	3.69e-05	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—AKT1—obesity	6.11e-06	3.69e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MAPK8—obesity	6.08e-06	3.68e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—AKT1—obesity	6.07e-06	3.67e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IRS1—obesity	6.04e-06	3.65e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PIK3CG—obesity	6.01e-06	3.63e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—IL6—obesity	6.01e-06	3.63e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IRS1—obesity	5.94e-06	3.59e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—POMC—obesity	5.82e-06	3.52e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—INS—obesity	5.79e-06	3.5e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—POMC—obesity	5.72e-06	3.46e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MMP9—obesity	5.72e-06	3.45e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—INS—obesity	5.69e-06	3.44e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCL2—obesity	5.69e-06	3.44e-05	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—AKT1—obesity	5.68e-06	3.43e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCL2—obesity	5.6e-06	3.38e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IGF1—obesity	5.6e-06	3.38e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—IL6—obesity	5.59e-06	3.38e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—AKT2—obesity	5.59e-06	3.38e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—STAT3—obesity	5.56e-06	3.36e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MAPK8—obesity	5.56e-06	3.36e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—AKT1—obesity	5.54e-06	3.35e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IGF1—obesity	5.51e-06	3.33e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—AKT2—obesity	5.5e-06	3.33e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PIK3CD—obesity	5.37e-06	3.25e-05	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—PIK3CA—obesity	5.32e-06	3.22e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MMP9—obesity	5.32e-06	3.21e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—SERPINE1—obesity	5.31e-06	3.21e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PIK3CD—obesity	5.29e-06	3.19e-05	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—PIK3CA—obesity	5.24e-06	3.16e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—SERPINE1—obesity	5.23e-06	3.16e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MAPK8—obesity	5.17e-06	3.13e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TYK2—obesity	5.17e-06	3.12e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MYC—obesity	5.17e-06	3.12e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—AKT1—obesity	5.16e-06	3.12e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—TGFB1—obesity	5.16e-06	3.12e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—RHOA—obesity	5.13e-06	3.1e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TYK2—obesity	5.09e-06	3.07e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—STAT3—obesity	5.08e-06	3.07e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PIK3R1—obesity	5.07e-06	3.07e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—NOS3—obesity	5.07e-06	3.07e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—RHOA—obesity	5.04e-06	3.05e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PIK3R1—obesity	4.99e-06	3.02e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—NOS3—obesity	4.99e-06	3.02e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—PIK3CA—obesity	4.83e-06	2.92e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—PIK3CA—obesity	4.76e-06	2.87e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—STAT3—obesity	4.73e-06	2.86e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MYC—obesity	4.72e-06	2.85e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—TGFB1—obesity	4.71e-06	2.85e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MTOR—obesity	4.68e-06	2.83e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PIK3CB—obesity	4.68e-06	2.83e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PIK3CB—obesity	4.61e-06	2.78e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MTOR—obesity	4.61e-06	2.78e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MYC—obesity	4.39e-06	2.66e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PIK3CA—obesity	4.39e-06	2.65e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—TGFB1—obesity	4.38e-06	2.65e-05	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—AKT1—obesity	4.35e-06	2.63e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—IL6—obesity	4.28e-06	2.59e-05	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—AKT1—obesity	4.28e-06	2.59e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—IL6—obesity	4.21e-06	2.54e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MMP9—obesity	4.07e-06	2.46e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PIK3CA—obesity	4.01e-06	2.42e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MMP9—obesity	4.01e-06	2.42e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MAPK8—obesity	3.96e-06	2.39e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—AKT1—obesity	3.95e-06	2.39e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MAPK8—obesity	3.9e-06	2.35e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IL6—obesity	3.89e-06	2.35e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—AKT1—obesity	3.88e-06	2.35e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PIK3CA—obesity	3.73e-06	2.25e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—STAT3—obesity	3.62e-06	2.19e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—AKT1—obesity	3.58e-06	2.17e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—STAT3—obesity	3.56e-06	2.15e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IL6—obesity	3.55e-06	2.15e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MYC—obesity	3.36e-06	2.03e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TGFB1—obesity	3.35e-06	2.03e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MYC—obesity	3.31e-06	2e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IL6—obesity	3.3e-06	2e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TGFB1—obesity	3.3e-06	1.99e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—AKT1—obesity	3.28e-06	1.98e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—AKT1—obesity	3.05e-06	1.84e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PIK3CA—obesity	2.85e-06	1.73e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PIK3CA—obesity	2.81e-06	1.7e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IL6—obesity	2.53e-06	1.53e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IL6—obesity	2.49e-06	1.5e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—AKT1—obesity	2.33e-06	1.41e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—AKT1—obesity	2.29e-06	1.39e-05	CbGpPWpGaD
